{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:51:09Z","timestamp":1783025469711,"version":"3.54.6"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00115-022-01344-9","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T15:02:48Z","timestamp":1655305368000},"page":"1247-1249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Das Anti-IgLON5-Syndrom in der klinischen Neurologie\u00a0\u2013 zwei Fallberichte","The anti-IgLON5 syndrome in clinical neurology\u2014Report of two cases"],"prefix":"10.1007","volume":"93","author":[{"given":"Johanna","family":"Niederschweiberer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas U.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Kumpfm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lingg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benno","family":"Ikenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"M\u00fchlau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lingor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Hemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Knier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/ane.13207","volume":"141","author":"P Cabezudo-Garc\u00eda","year":"2020","unstructured":"Cabezudo-Garc\u00eda\u00a0P, Mena-V\u00e1zquez\u00a0N, Estivill Torr\u00fas\u00a0G et al (2020) Response to immunotherapy in anti-IgLON5 disease: a systematic review. Acta Neurol Scand 141:263\u2013270","journal-title":"Acta Neurol Scand"},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"e15706","DOI":"10.1097\/MD.0000000000015706","volume":"98","author":"HY Chung","year":"2019","unstructured":"Chung\u00a0HY, Wickel\u00a0J, Voss\u00a0A et al (2019) Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: a case report. Medicine 98:e15706","journal-title":"Medicine"},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"e1367","DOI":"10.1212\/WNL.0000000000012639","volume":"97","author":"C Gaig","year":"2021","unstructured":"Gaig\u00a0C, Compta\u00a0Y, Heidbreder\u00a0A et al (2021) Frequency and characterization of movement disorders in anti-IgLON5 disease. Neurology 97:e1367\u20131381","journal-title":"Neurology"},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig\u00a0C, Graus\u00a0F, Compta\u00a0Y et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743","journal-title":"Neurology"},{"key":"1344_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsz133","author":"C Gaig","year":"2019","unstructured":"Gaig C, Iranzo A, Cajochen C et al (2019) Characterization of the sleep disorder of anti-IgLON5 disease. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsz133","journal-title":"Sleep"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00401-016-1591-8","volume":"132","author":"E Gelpi","year":"2016","unstructured":"Gelpi\u00a0E, H\u00f6ftberger\u00a0R, Graus\u00a0F et al (2016) Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol 132:531\u2013543","journal-title":"Acta Neuropathol"},{"key":"1344_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac090","author":"T Gr\u00fcter","year":"2022","unstructured":"Gr\u00fcter T, M\u00f6llers FE, Tietz A et al (2022) Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease. Brain. https:\/\/doi.org\/10.1093\/brain\/awac090","journal-title":"Brain."},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11940-018-0515-4","volume":"20","author":"A Heidbreder","year":"2018","unstructured":"Heidbreder\u00a0A, Philipp\u00a0K (2018) Anti-IgLON 5 disease. Curr Treat Options Neurol 20:29","journal-title":"Curr Treat Options Neurol"},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/ana.25857","volume":"88","author":"J Landa","year":"2020","unstructured":"Landa\u00a0J, Gaig\u00a0C, Plagum\u00e0\u00a0J et\u00a0al (2020) Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration. Ann Neurol 88:1023\u20131027","journal-title":"Ann Neurol"},{"key":"1344_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater\u00a0L, Gaig\u00a0C, Gelpi\u00a0E et al (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a\u00a0case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586","journal-title":"Lancet Neurol"},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnins.2017.00038","volume":"11","author":"T Vanaveski","year":"2017","unstructured":"Vanaveski\u00a0T, Singh\u00a0K, Narvik\u00a0J et al (2017) Promoter-Specific Expression and Genomic Structure of IgLON Family Genes in Mouse. Front Neurosci 11:38","journal-title":"Front Neurosci"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-022-01344-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-022-01344-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T13:07:59Z","timestamp":1669986479000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-022-01344-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1007\/s00115-022-01344-9","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"23 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Niederschweiberer, N.U.\u00a0Schumacher, D.\u00a0Kumpfm\u00fcller, C.\u00a0Lingg, S.\u00a0Graf, B.\u00a0Ikenberg, M.\u00a0M\u00fchlau, P.\u00a0Lingor, B.\u00a0Hemmer und B.\u00a0Knier geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}